|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/00 | |
| A61K 38/29 | |||
| A61P 19/08 | |||
| A61P 19/10 | |||
| A61K 38/22 | |||
| A61K 38/27 | |||
| A61K 38/17 |
| (11) | Number of the document | 2914277 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13851864.2 |
| Date of filing the European patent application | 2013-11-01 | |
| (97) | Date of publication of the European application | 2015-09-09 |
| (45) | Date of publication and mention of the grant of the patent | 2017-09-13 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2013/068009 |
| Date | 2013-11-01 |
| (87) | Number | WO 2014/071158 |
| Date | 2014-05-08 |
| (30) | Number | Date | Country code |
| 201261721898 P | 2012-11-02 | US | |
| 201261740665 P | 2012-12-21 | US |
| (72) |
SLOAN, Victor, Schorr, US
HRUSKA, Keith, US
FANG, Yifu, US
SUNG, Victoria, US
STEVENS, Randall, US
SMITH, William, US
|
| (73) |
Celgene Corporation,
86 Morris Avenue, Summit, NJ 07901,
US
Washington University, One Brookings Drive, Saint Louis, MO 63130, US Sloan, Victor Schorr, 34 Stirrup Lane, Flemington, NJ 08822, US Hruska, Keith, One Brookings Drive, St. Louis, MO 63130, US Fang, Yifu, One Brookings Drive, St. Louis, MO 63130, US |
| (54) | ACTIVIN-ACTRII ANTAGONISTS AND USES FOR TREATING BONE AND OTHER DISORDERS |
| ACTIVIN-ACTRII ANTAGONISTS AND USES FOR TREATING BONE AND OTHER DISORDERS |